Your browser doesn't support javascript.
loading
Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients.
Berardinelli, Gustavo Noriz; Scapulatempo-Neto, Cristovam; Durães, Ronílson; Antônio de Oliveira, Marco; Guimarães, Denise; Reis, Rui Manuel.
Affiliation
  • Berardinelli GN; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
  • Scapulatempo-Neto C; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
  • Durães R; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
  • Antônio de Oliveira M; Department of Oncology, Barretos Cancer Hospital, Jales, São Paulo, Brazil.
  • Guimarães D; Nucleus of Epidemiology and Biostatistics, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
  • Reis RM; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Oncotarget ; 9(47): 28691-28701, 2018 Jun 19.
Article in En | MEDLINE | ID: mdl-29983889

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Oncotarget Year: 2018 Document type: Article Affiliation country: Brazil Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Oncotarget Year: 2018 Document type: Article Affiliation country: Brazil Country of publication: United States